The purity of Human Fas Ligand, His Tag, active trimer (Cat. No. FAL-H5241) was more than 90% and the molecular weight of this protein is around 65-85 kDa verified by SEC-MALS.
Immobilized Human Fas Ligand, His Tag, active trimer (Cat. No. FAL-H5241) at 2 μg/mL (100 μL/well) can bind Human Fas, Fc Tag (Cat. No. FAS-H5252) with a linear range of 0.003-0.062 μg/mL (QC tested).
Immobilized Human Fas Ligand, His Tag, active trimer (Cat. No. FAL-H5241) at 2 μg/mL (100 μL/well) can bind Human Fas, Fc Tag (Cat. No. FAS-H5252) with a linear range of 0.003-0.062 μg/mL (QC tested).
Fas ligand is also known as FasL, CD178, CD95L, or TNFSF6, is a homotrimeric type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. Its binding with its receptor induces apoptosis. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer. Mature human Fas Ligand consists of a 179 amino acid (aa) extracellular domain (ECD), a 22 aa transmembrane segment, and a 80 aa cytoplasmic domain. Within the ECD, human Fas Ligand shares 81% and 78% aa sequence identity with mouse and rat Fas Ligand, respectively. Apoptosis triggered by Fas-Fas ligand binding plays a fundamental role in the regulation of the immune system. Its functions include:T-cell homeostasis, cytotoxic T-cell activity, immune privilege, maternal tolerance, tumor counterattack. Defective Fas-mediated apoptosis may lead to oncogenesis as well as drug resistance in existing tumors. Germline mutation of Fas is associated with autoimmune lymphoproliferative syndrome (ALPS), a childhood disorder of apoptosis.
A-Z